List of life sciences

Quantiphi Earns Frost & Sullivan's North America Competitive Strategy Leadership Award in Artificial Intelligence Services for the Healthcare Industry

Retrieved on:

Monday, August 8, 2022 - 8:00pm

MARLBOROUGH, Mass., Aug. 8, 2022 /PRNewswire-PRWeb/ -- Quantiphi, an AI-first digital engineering company, has been awarded the Frost & Sullivan's North America Competitive Strategy Leadership Award in AI Services for the Healthcare Industry. Frost & Sullivan recognizes companies that are at the forefront of innovation and growth in their respective industries, and consistently develop growth strategies to solve challenges and create new opportunities effectively.

Key Points:

MARLBOROUGH, Mass., Aug. 8, 2022 /PRNewswire-PRWeb/ -- Quantiphi, an AI-first digital engineering company, has been awarded the Frost & Sullivan's North America Competitive Strategy Leadership Award in AI Services for the Healthcare Industry.
The award comes to Quantiphi after qualifying through a rigorous analytical process established by Frost & Sullivan that evaluates best practices criteria across strategy, innovation, and customer impact.
By strategically broadening its offering portfolios, Quantiphi has successfully addressed the compounding challenges of disruptive technologies, value chain compression, industry convergence, and changing business models within the healthcare industry.
Frost & Sullivan cited many of Quantiphi's success stories and achievements in its report, strengthening Quantiphi's position as a Competitive Strategy Leader in the AI services in the healthcare industry.

Global Manufacturing Execution Systems Market Report 2022-2027: Opportunities in the Integration of MES with Solutions such as ERP and PLM

Retrieved on:

Monday, August 8, 2022 - 5:00pm

The global manufacturing execution systems market is expected to grow from USD 13 billion in 2022 to USD 20 billion by 2027, at a CAGR of 9%

Key Points:

The global manufacturing execution systems market is expected to grow from USD 13 billion in 2022 to USD 20 billion by 2027, at a CAGR of 9%
The use of hybrid deployment type for manufacturing execution systems market and an inclination towards services to fuel the growth of manufacturing execution systems market.
The foreseeable decline in the growth of end-user industries may have a considerable direct impact on the manufacturing execution systems market.
In automotive manufacturing plants, manufacturing execution systems are used to deliver information that enables the optimization of production activities from order launch to finished goods.
North America accounted for largest market share of the global manufacturing execution systems market in 2021.

Solomon Partners Expands Healthcare Team with Hiring of Aryeh Sand

Retrieved on:

Monday, August 8, 2022 - 3:00pm

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Solomon Partners , a leading financial advisory firm, has appointed Aryeh Sand as a Managing Director in its Global Healthcare Group .

Key Points:

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Solomon Partners , a leading financial advisory firm, has appointed Aryeh Sand as a Managing Director in its Global Healthcare Group .
Sand will be based in New York and report to Jon Hammack, Head of the Healthcare Group.
Solomon Partners Healthcare Group provides differentiated advisory services to clients across the healthcare ecosystem.
Since the groups inception, coverage has included Medical Devices / Technology, Outsourced Services, Healthcare Technology & Tech-Enabled Services, Pharmacy & Pharmacy Services, Healthcare Services, and Consumer Healthcare.

Signant Partners with Loftware for Adaptive Investigational Product Labeling

Retrieved on:

Monday, August 8, 2022 - 2:00pm

Guest appearance, Electronics, Content management, Industry, Clinical trial, Product management, Compliance, Health, NEMS Enterprises (label), Foodservice, List of life sciences, Partnership, Solution, Cros, Efficiency, Dietary supplement, Medical device

PHILADELPHIA, Aug. 8, 2022 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced a partnership with Loftware to offer customers integrated clinical trial supply labeling and packaging capabilities. Loftware is the leading provider of labeling and regulated content solutions and can now be integrated with Signant's SmartSignals™ Supplies solutions to provide customers with a seamless product label design, approval, and production process.

Key Points:

Loftware is the leading provider of labeling and regulated content solutions and can now be integrated with Signant's SmartSignals Supplies solutions to provide customers with a seamless product label design, approval, and production process.
The partnership with Loftware allows Signant customers to take advantage of enhanced regulatory control, direct booklet label design/print, and the advancement of in-line camera verification of labels, as the industry moves towards a 'just-in-time' labeling approach.
"In response to demand we are partnering with Signant to offer customers an integrated solution to streamline the clinical supply labeling print processes.
Loftwareis the world's largest cloud-based Enterprise Labeling and Artwork Management provider, offering an end-to-end labeling solution platform for companies of all sizes.

Signant Partners with Loftware for Adaptive Investigational Product Labeling

Retrieved on:

Monday, August 8, 2022 - 2:00pm

PHILADELPHIA, Aug. 8, 2022 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced a partnership with Loftware to offer customers integrated clinical trial supply labeling and packaging capabilities. Loftware is the leading provider of labeling and regulated content solutions and can now be integrated with Signant's SmartSignals™ Supplies solutions to provide customers with a seamless product label design, approval, and production process.

Key Points:

Loftware is the leading provider of labeling and regulated content solutions and can now be integrated with Signant's SmartSignals Supplies solutions to provide customers with a seamless product label design, approval, and production process.
The partnership with Loftware allows Signant customers to take advantage of enhanced regulatory control, direct booklet label design/print, and the advancement of in-line camera verification of labels, as the industry moves towards a 'just-in-time' labeling approach.
"In response to demand we are partnering with Signant to offer customers an integrated solution to streamline the clinical supply labeling print processes.
Loftwareis the world's largest cloud-based Enterprise Labeling and Artwork Management provider, offering an end-to-end labeling solution platform for companies of all sizes.

Healthcare Triangle, Inc (HCTI) Reports Results for the Second Quarter of 2022

Retrieved on:

Monday, August 8, 2022 - 1:10pm

Cloud, Risk, Industry, CEO, GLOBE, Forward-looking statement, Private Securities Litigation Reform Act, SEC, Investment, Achievement, HCTI, Company, List of life sciences, Acosta Sales & Marketing, News, IEEE Medal for Innovations in Healthcare Technology, Health care, Video game, Security (finance)

PLEASANTON, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc(HCTI), a leading provider of cloud and digital transformation, managed services and data analytics platform for Healthcare and Life Sciences industry reported results for the quarter ended June 30, 2022.

Key Points:

PLEASANTON, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc(HCTI), a leading provider of cloud and digital transformation, managed services and data analytics platform for Healthcare and Life Sciences industry reported results for the quarter ended June 30, 2022.
In Q2, we accelerated our revenue growth; the strong operational performance reflects the customer adoption and strength of our offerings.
Revenue in the second quarter of 2022 totaled $11.6 million, up 15% from 10 million.
Subsequent to the quarter ended June 30, 2022, the company raised $6.50 million through a private placement.

Edmund Optics Focuses on Expansion with the Hire of James Fisher, Former Newport Executive

Retrieved on:

Monday, August 8, 2022 - 2:00pm

Industry, GLOBE, Senior, VP, OEM, R, University, University of Illinois Urbana-Champaign, List of life sciences, COO, Corporate development, Engineering, MBA, Defense, Catalog, Management, Biomedicine

BARRINGTON, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Edmund Optics, a leading global manufacturer and supplier of optical components, announced today the hire of James Fisher as Senior Vice President of Corporate Development.

Key Points:

BARRINGTON, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Edmund Optics, a leading global manufacturer and supplier of optical components, announced today the hire of James Fisher as Senior Vice President of Corporate Development.
James brings 20 years' experience in the photonics industry as the former VP/General Manager of MKS/Newport's Photonics Business Unit and has previously served as a member of the Edmund Optics Board of Directors since 2018.
James will leverage his extensive company and industry relationships to identify growth opportunities for Edmund Optics.
Operating in more than a dozen major facilities around the globe, Edmund Optics employs just over 1,100 employees and continues to expand.

Triverus Consulting Welcomes Lisa Burgese Fry as Director of Business Development

Retrieved on:

Monday, August 8, 2022 - 1:15pm

Multimedia, Public sector, Technology, Growth, Business development, Data-intensive computing, List of life sciences, Biotechnology, WBE, MACOM Technology Solutions, Goal, Information technology, Organization, Audit, Risk management

WOBURN, Mass., Aug. 8, 2022 /PRNewswire/ --TriverusConsultinghas announced thatLisa Burgese Fry will be joining Triverus as Director of Business Development, effective August 8, 2022.

Key Points:

WOBURN, Mass., Aug. 8, 2022 /PRNewswire/ --TriverusConsultinghas announced thatLisa Burgese Fry will be joining Triverus as Director of Business Development, effective August 8, 2022.
As a Director of Business Development, Lisawill support our clients by applying Triverus' services to help our clients achieve meaningful outcomes addressing theirbusiness opportunities, challenges, and goals.
Lisa will bring to bear a proven track record in account management, channel management, change management, and direct sales to support Triverus' continued growth.
Triverushelps clients realize their business objectives by providing information technology expertise and services, based on proven approaches and by leveragingaccelerators.

PureSoftware and TFI Research release 'The Global Report on Conversation AI for Banks 2022'

Retrieved on:

Monday, August 8, 2022 - 1:00pm

Cloud, Chief digital officer, City, Digital transformation, AI, Technology, Customer communications management, Research, Financial services, Casino game, Chatbot, List of life sciences, Community, Reader, Time, Telecom, Conversation, Health care, Online shopping

SINGAPORE, Aug. 8, 2022 /PRNewswire/ -- PureSoftware, a global software products and services company, together with TFI Research, a global leader in market surveys and integrated insights have conducted a comprehensive study on conversational AI in banks and released 'The Global Report on Conversational AI for Banks 2022.'

Key Points:

SINGAPORE, Aug. 8, 2022 /PRNewswire/ -- PureSoftware, a global software products and services company, together with TFI Research, a global leader in market surveys and integrated insights have conducted a comprehensive study on conversational AI in banks and released 'The Global Report on Conversational AI for Banks 2022.'
The report includes detailed insights into conversational AI in banks, the evolution of AI besides its application within the banks, and how the technology is shaping the next-gen banking experience.
Conversational AI is set to usher in the new era of human-bot collaboration in the banks around the world.
Since 2009, TFI Research has grown into the world's finest research company with more than 10,000 experts and a network in 183+ countries.

Pyramid Biosciences Names Nushmia Khokhar, MD, as Chief Medical Officer

Retrieved on:

Monday, August 8, 2022 - 12:30pm

Nushmia Khokhar, MD has joined the company as Chief Medical Officer, where she will oversee the advancement and expansion of the Companys clinical pipeline.

Key Points:

Nushmia Khokhar, MD has joined the company as Chief Medical Officer, where she will oversee the advancement and expansion of the Companys clinical pipeline.
Dr. Khokhar has a proven track record of successfully bringing novel oncology compounds through clinical development to global approval, said CEO of Pyramid Biosciences, Brian Lestini, MD, PhD.
We are looking forward to Dr. Khokhars leadership of our clinical programs during this important growth stage of our company.
Prior to joining Pyramid Biosciences, Dr. Khokhar served as Chief Medical Officer at Umoja Biopharma, a multi-platform, immuno-oncology company based in Seattle, WA.